Phillips-Medisize Corporation announced plans to open a new 80,000 square foot manufacturing facility on its Menomonie, Wisconsin campus. The state-of-the-art facility manufactures high volume prefilled drug delivery systems, and is planned to be complete in 2017. Investment in the new facility is d…

INNOVATIVE SOLUTIONS: Phillips-Medisize will present solutions for development and manufacture of medical devices in drug delivery, consumable diagnostics, and medical/surgical consumable technologies at COMPAMED in Dusseldorf, Germany, 14-17 November 2016 (hall 8a, stand H15). The wide variety of c…

Extends Footprint into Northeastern United States and Enhances Services to Biopharma, Consumable Diagnostics and Medical Device Customers.

Phillips-Medisize Corporation (the “Company”) today announced that it has agreed to acquire Injectronics, Inc (“Injectronics”). Injectronics provides cont…

Phillips-Medisize Corporation (the “Company”) today announced that it has acquired Medicom Innovation Partner (“Medicom”), a leading provider of device strategy, product design and development services with particular focus on personal connected health drug delivery device solutions to meet…

“A brilliant medical device idea, but is it technically feasible and scalable?” Phillips-Medisize regularly addresses these questions when developers and customers discuss their first medical device design with the renowned outsourcing partner. The dialogue leads from R&D through to the read…

Phillips-Medisize Corp. recently added a 17,000 square foot clinical and pilot facility, dedicated to medical device and drug delivery device, in Menomonie, Wisconsin. This dedicated facility is a direct result of the company’s continued commitment to purpose-built facilities and the support of se…

Phillips-Medisize will show specialized visitors its expertise in designing, developing and manufacturing drug delivery devices as well as pharmaceutical primary packaging made of plastics during the Pharmapack exposition in Paris on 10-11 February 2016. A wide variety of products will be displayed…

Phillips-Medisize Corp. representatives Bill Welch, Chief Technology Officer, and Janne Turunen, Program Manager, will be part of the Sanofi presentation at the Partnership Opportunities in Drug Delivery (PODD) in Boston, Massachusetts on October 5, 2015.

The PODD conference brings together leaders i…

Phillips-Medisize Corporation announced the completion of a 5,000 sq. ft. expansion to its Hudson, Wisconsin, Design and Development Center (DDC). This new space will be occupied with expanded biopharmaceutical drug delivery and medical device test engineering capabilities including test method deve…

Today, Phillips-Medisize Corporation announced the opening of its new design and development center in Suzhou, China. Growth of the company’s design and
development centers supports its customers’ needs for patient-administered biologics and pharmaceutical drug delivery and diagnostics device design…